PortfoliosLab logo

Bolt Biotherapeutics, Inc. (BOLT)

Equity · Currency in USD · Last updated Mar 24, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Bolt Biotherapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $407 for a total return of roughly -95.93%. All prices are adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2023FebruaryMarch
-95.93%
1.59%
BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BOLT

Bolt Biotherapeutics, Inc.

Return

Bolt Biotherapeutics, Inc. had a return of 0.77% year-to-date (YTD) and -57.61% in the last 12 months. Over the past 10 years, Bolt Biotherapeutics, Inc. had an annualized return of -77.85%, while the S&P 500 had an annualized return of 0.75%, indicating that Bolt Biotherapeutics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-12.08%-3.20%
Year-To-Date0.77%2.84%
6 months-25.57%4.19%
1 year-57.61%-12.48%
5 years (annualized)-77.85%0.75%
10 years (annualized)-77.85%0.75%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202313.08%9.52%
2022-17.78%-6.08%6.47%-12.16%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bolt Biotherapeutics, Inc. Sharpe ratio is -0.80. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20NovemberDecember2023FebruaryMarch
-0.80
-0.54
BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Bolt Biotherapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-96.72%
-17.68%
BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bolt Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bolt Biotherapeutics, Inc. is 96.84%, recorded on Dec 20, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.84%Mar 18, 2021445Dec 20, 2022
-22.7%Feb 11, 202111Feb 26, 20217Mar 9, 202118
-0.51%Mar 15, 20211Mar 15, 20211Mar 16, 20212
-0.2%Mar 10, 20211Mar 10, 20211Mar 11, 20212

Volatility Chart

Current Bolt Biotherapeutics, Inc. volatility is 88.29%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%NovemberDecember2023FebruaryMarch
88.29%
19.59%
BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)